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Type XI collagen is a quantitatively minor yet essen-
tial constituent of the cartilage extracellular matrix.
The amino propeptide of the 1 chain remains attached
to the rest of the molecule for a longer period of time
after synthesis than the other amino propeptides of type
XI collagen and has been localized to the surface of thin
collagen fibrils. Yeast two-hybrid system was used to
demonstrate that a homodimer of 1(XI) amino propep-
tide (1(XI)Npp) could form in vivo. Interaction was also
confirmed using multi-angle laser light scattering, de-
tecting an absolute weight average molar mass ranging
from the size of a monomer to the size of a dimer (25,000–
50,000 g/mol), respectively. Binding was shown to be
saturable by ELISA. An interaction between recombi-
nant 1(XI)Npp and the endogenous 1(XI)Npp was ob-
served, and specificity for 1(XI)Npp but not 2(XI)Npp
was demonstrated by co-precipitation. The interaction
between the recombinant form of 1(XI)Npp and the
endogenous 1(XI)Npp resulted in a stable association
during the regeneration of cartilage extracellular ma-
trix by fetal bovine chondrocytes maintained in pellet
culture, generating a protein that migrated with an ap-
parent molecular mass of 50–60 kDa on an SDS-poly-
acrylamide gel.
Type XI collagen is a constituent of the extracellular matrix
of cartilage. It belongs to the family of fibrillar collagens, which
includes types I, II, III, V, and XI (1). As with all of the fibrillar
collagens, type XI contains a 300-nm uninterrupted triple hel-
ical domain (2). Type XI collagen forms the heterotypic collagen
fibrils characteristic of cartilage along with types II and the
nonfibrillar type IX collagen (3). Although minor in quantity,
type XI collagen is thought to play a critical role in collagen
fibril assembly and extracellular matrix organization in early
development as demonstrated by the chondrodystrophic mouse
(cho/cho) (4). Fibrils of developing cartilage are of uniform 20
nm in diameter and oriented more randomly than fibrils of
adult articular cartilage.
Collagen fibril assembly in embryonic cartilage is known to
rely upon the ratio of the collagenous constituents, types II and
XI (5). Initially, type XI collagen may function to nucleate the
formation of new collagen fibrils (6). The role of type XI colla-
gen in limitation of lateral growth of collagen fibrils is well
established, although the molecular mechanism is not fully
understood. Type XI collagen may also play a role in the mat-
uration of thin fibrils into the larger diameter fibrils of the
territorial zone of cartilage matrix, either by regulation of the
accretion of more collagen molecules onto the surface of thin
fibrils or by mediating the fusion of thin fibrils.
Type XI collagen is initially synthesized as a procollagen,
which is subsequently proteolytically processed at both the
amino and carboxyl termini (7). The amino-terminal processing
site was identified 7 amino acids from the variable region (8, 9).
Recently, type XI 1 pro-collagen was identified as a substrate
for the enzyme bone morphogenetic protein 1 (BMP-1)1 (10).
The carboxyl propeptide of the 1 chain of type XI collagen is
homologous to the other fibrillar collagens, whereas the amino
propeptide of type XI 1 pro-collagen is markedly different. In
addition to the characteristic minor triple helix, the 1 chain of
XI contains a large non-triple helical domain at the amino
terminus.
The 1 chain of type XI collagen exists as a set of isoforms
that arise by alternative splicing of the primary RNA tran-
script (11). The portion encoding the variable region gives rise
to biochemically unique domains. However, common to all iso-
forms is the amino propeptide, the distal globular 233 amino
acids, which is ultimately proteolytically removed during the
process of extracellular matrix assembly and fibril formation.
Proteolytic removal of the amino propeptide may rely on the
action of BMP-1, as it does in the case of 1(V) collagen chain
(12).
The amino propeptide domain is structurally related to other
amino propeptides including that of the 2(XI) and 1(V) col-
lagen chains. The position of four cysteine residues are con-
served, and sequence analysis predicts a conserved secondary
structural motif rich in -strand (13). This prediction has been
supported by analysis of circular dichroism spectra, demon-
strating a relatively high percentage -strand and a markedly
low percentage of  helix (14). The dimensions of the globular
amino propeptide domain of 1(XI) collagen chain has been
estimated by rotary shadowing to be at least 8 nm in diameter.
This domain has been localized to the surface of collagen fibrils
by immunoelectron microscopy (15).
Although the amino propeptides are ultimately removed
from the collagen triple helical molecule by proteolytic process-
ing, the rate and extent of removal vary. Although the process-
ing of 1(XI) collagen chain is relatively slow, thus achieving
50% completion by 18 h after synthesis in pulse-chase experi-
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ments, the processing of the 2(XI) collagen chain is much
faster, 75% complete by 5 h after synthesis (16). This raises the
possibility that the amino propeptides carry out different func-
tions and that the 1(XI) amino propeptide may function while
still retained on the surface of collagen fibrils for the extended
period of time after synthesis. Globular domains poised on the
surface of newly synthesized collagen fibrils may play a role in
both the mechanism of growth of an individual fibril as well as
lateral fusion of neighboring collagen fibrils or interaction be-
tween the collagen fibrils and other constituents of the extra-
cellular matrix.
We report the interaction between amino propeptide do-
mains of 1(XI) collagen chains. The interaction had a dissoci-
ation constant on the order of 130 nM. This interaction was
stabilized in cell culture by an association that was not dis-
rupted by reducing agents, EDTA, SDS, or heat. Such an in-
teraction may explain, in part, how collagen XI functions to
regulate growth of collagen fibrils in developing tissues.
EXPERIMENTAL PROCEDURES
Synthesis and Purification of Recombinant Rat 1(XI)Npp Do-
main—A cDNA fragment encoding the amino propeptide of 1 chain of
type XI collagen was inserted into expression vector pET11a (Strat-
agene). BL21 DE3 transformants were screened for expression of re-
combinant protein on SDS-polyacrylamide gels and subsequent trans-
fer to polyvinylidene difluoride membrane for detection of recombinant
proteins by nickel affinity blot using nickel-NTA conjugated to alkaline
phosphatase (Qiagen). Cells from transformant cultures were collected
by centrifugation, and proteins were solubilized using bacterial protein
extraction reagent (Pierce) with 1 unit of DNase I per 10 ml of cell
suspension. This extraction solubilized the majority of cellular proteins,
leaving recombinant 1(XI) amino propeptide (1(XI)Npp) insoluble in
the inclusion bodies. Protein from inclusion bodies was solubilized and
unfolded in 20 mM Tris-HCl, pH 7.5, with freshly prepared 8 M urea, and
14 mM -mercaptoethanol at a protein concentration of 1 mg/ml.
Refolding was initiated by diluting solubilized unfolded protein drop-
wise and with stirring into 100 volumes of 20 mM Tris-HCl, pH 7.5,
containing 100 mM KCl, 20% glycerol, and 2 M urea at 4 °C. Incubation
at 4 °C was continued for 16 h. Refolded protein was concentrated by
ultrafiltration using a Centriprep filtration unit (Amicon). Insoluble
material, if present, was removed by centrifugation. Refolded protein
was further purified by chelation chromatography on a Hi-Trap nickel
column (Amersham Biosciences) (Fig. 1). Disulfide-bonded cysteine
pairs were verified by tryptic digest followed by protein sequencing of
those bands present in the absence of 10 mM DTT but absent when the
sample was treated with reducing agent as described previously (17).
Refolded protein was characterized by circular dichroism and com-
pared with native protein isolated from tissue (17). Npp without a
His6 tag was generated by removing the carboxyl portion of a recom-
binant 1(XI) amino-terminal domain containing the variable region
(1(XI)NTD), which contains a functional BMP-1 proteolytic process-
ing site (10). Recombinant protein was incubated in the presence of
purified recombinant human BMP-1 (FibroGen, Inc.) as described
previously (10).
Yeast Two-hybrid System—A protein-protein interaction was tested
in vivo using Matchmaker GAL4 (Clontech, Inc.) yeast two-hybrid sys-
tem. cDNA encoding 1(XI)Npp was obtained by reverse transcription-
PCR using the following primers: 5-cca tgg ttg ata tac tga aag ctt tag
at-3 and 5-att agg atc ctc atc tat gtg cgg ctc ctg-3. This fragment
was used to make two different gene fusions: one with the DNA
binding domain of GAL4 and the other with the transcriptional
activation domain of GAL4 in the plasmids pGBKT7 and pGADT7,
respectively.
Yeast host strain AH109 was transformed using the lithium acetate
method (17). Selection of positive transformants was carried out by
plating on SD minimal medium agar plates lacking the nutrient leucine
and tryptophan to select for the plasmids derived from pGBKT7 and
pGADT7, respectively. Plates lacking both nutrients were used to select
for double transformants.
To select for colonies in which the two-hybrid proteins interact, double
transformants were plated on SD minimal medium lacking tryptophan,
leucine, and histidine. Protein-protein interaction was verified by deter-
mining the expression of -galactosidase activity by colony-lift filter assay
and by determining the level of expression in liquid culture using chloro-
phenol red--D-galactopyranoside as substrate (Clontech).
Weight Average Molecular Weight Determination by Light Scatter-
ing—Recombinant 1(XI)Npp was applied to a TSK 3000SW size ex-
clusion column at 10 °C in the following buffer: 30 mM Na2HPO4, 45 mM
KH2PO4, pH 6.6, containing 100 mM KCl. The eluting peak was ana-
lyzed using a refractive index detector, a UV monitor, and by multi-
angle laser light scatter (DAWN, Wyatt Technology, Santa Barbara,
CA) to determine the absolute molecular weight of 1(XI)Npp in solu-
tion. A vertically polarized laser beam was passed through the flow cell
containing the sample. The scattered light was simultaneously de-
tected by 18 separate detectors at different angles. The intensity of
the scattered light was digitized and transmitted to a computer for
analysis by software provided by the manufacturer. The weight-
average molar mass was determined from the Rayleigh ratio of scat-
tered light, molecular concentration in grams/milliliters, and the
specific refractive index increment of the dissolved molecules (dn/dc).
The concentration was determined from the refractive index at each
slice of the chromatogram and also from the absorbance at 280 nm
and the 0.1% extinction coefficient, calculated for recombinant rat
1(XI)Npp to be 0.548 assuming all cysteine residues exist as half-
cystines. The dn/dc value used was 0.185. Recombinant 1(XI)Npp
was analyzed under three salt conditions: 75, 175, and 500 mM with
respect to additive concentration of KCl and buffer components. Mo-
lar mass was determined for individual slices of data across the
eluting size exclusion chromatographic peak and plotted as a function
of elution volume. Molecular weight at the leading and trailing edges
of the chromatographic peak was compared with to determine
whether recombinant 1(XI)Npp multimerized under the buffer con-
ditions of the column.
Antibodies—A peptide coding for the human 1(XI)Npp was used to
make the 1(XI)Npp antibody that showed specificity for the endoge-
nous 1(XI)Npp but not the recombinant 1(XI)Npp. Preparation and
characterization of this antibody was reported previously (18). The
ability of the 1(XI)Npp antibody to discriminate between endogenous
and recombinant 1(XI)Npp was demonstrated by immunoblot and
nickel affinity blot (Fig. 6). Samples of increasing amounts of recom-
binant 1(XI)Npp were loaded onto an SDS gel and subsequently
transferred to polyvinylidene difluoride membrane. Nickel-NTA-
alkaline phosphatase conjugate was used to detect recombinant pro-
tein from a sample that was three orders of magnitude more dilute
than the concentration needed for detection by the polyclonal anti-
body to 1(XI)Npp. Generation of the 2(XI)Npp antibody was carried
out using the sequence RERPQRQPSHRTQ from bovine sequence
(18) as the immunizing peptide. Antibody to the variable region of the
recombinant 1(XI) amino-terminal domain was described previously
(19).
ELISA Assay—Recombinant 1(XI)Npp was adsorbed to a microtiter
plate in 96-well format at room temperature. To block unoccupied sites
on plastic surface, wells were incubated with buffered skim milk pow-
der solution for 1 h at room temperature. Recombinant 1(XI)NTD was
allowed to interact with the 1(XI)Npp bound to the plate for 2 h at
room temperature. Antibody to the unique variable region was used to
detect interaction. Absorbance at 405 nm was plotted as a function of
the concentration of bound 1(XI)NTD with variable region detected.
This antibody did not recognize 1(XI)Npp. Nonspecific binding of the
primary antibody was tested in the absence of antigen. Nonspecific
binding of the secondary antibody was tested in the absence of primary
antibody. Bovine serum albumin was bound to the 96-well plate as a
control to detect nonspecific binding of 1(XI)NTD. Data was subjected
to Scatchard analysis to determine KD and Bmax.
Co-precipitation of Recombinant and Endogenous 1(XI)Npp Do-
mains—Recombinant 1(XI)Npp, synthesized with six histidine resi-
dues in tandem at the carboxyl terminus of the protein, was bound to
nickel-NTA-agarose (Qiagen) to investigate the specificity of the inter-
action between 1(XI)Npp domains. Protein was extracted from bovine
chondrocyte pellet cultures using 50 mM Tris-HCl, pH 7.5, 1 M NaCl,
and 5 mM EDTA. No denaturants such as guanidine hydrochloride or
urea were present during the extraction. Salt concentration was re-
duced to 150 mM by dialysis prior to incubation with 1(XI)Npp-bound
nickel-agarose. Material that bound to the recombinant 1(XI)Npp was
separated from that which did not bind by centrifugation. Samples were
analyzed by SDS-polyacrylamide gel electrophoresis followed by immu-
noblot using an antibody that recognized 1(XI)Npp and one that rec-
ognized a very similar domain, 2(XI)Npp.
Pellet Culture of Bovine Chondrocytes—Fetal bovine chondrocytes
were maintained in pellet culture (20). Where indicated in the text,
-aminopropionitrile fumarate was included in pellet culture medium
at a final concentration of 64 g/ml, putrescine was included at a final
concentration of 2 mM, AEBSF (4-(2-aminoethyl)-benzene sulfonyl-
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fluorideHCl) was included at a final concentration of 0.1 mM, and
recombinant 1(XI)Npp was included in tissue culture medium at a
concentration of 10 g/ml for 24 h. Proteins from medium and cell
pellets were analyzed by SDS-PAGE in the presence of -mercapto-
ethanol and subsequent immunoblot and nickel affinity blot.
RESULTS
Recombinant Rat 1(XI)Npp Domain—A 682-bp fragment
encoding 1(XI)Npp was obtained by reverse transcription-
PCR and inserted into the pET11a expression vector. Recom-
binant 1(XI)Npp was expressed as a fusion protein with
gene-10 gene product of bacteriophage T7, resulting in the
addition of amino acids MAS at the amino terminus of the
protein. Protein was expressed by BL21(DE3) Escherichia
coli cells upon isopropyl-1-thio--D-galactopyranoside induc-
tion. The DNA sequence of the insert was determined by
automated fluorescence DNA sequencing. The terminal me-
thionine was removed in the bacterial expression system as
verified by LCQ™MS/MS. The sequence of interest proceeded
from the first proline after the signal peptide processing site
of 1(XI) and continued to the glutamine one amino acid
before the amino propeptide processing site. Codons for six
histidine residues were included in the downstream PCR
primer immediately preceding a stop codon. The penultimate
amino acid, alanine, was changed conservatively to a valine
to allow the antibody to discriminate between endogenous
bovine 1(XI)Npp and recombinant rat 1(XI)Npp. In addi-
tion, this change modified the sequence at the proteolytic
processing site of 1(XI) collagen, reducing the chance that
the histidine tag would be removed from the recombinant
protein. Recombinant 1(XI)Npp with a His6 tag had a mo-
lecular weight of 24,826 g/mol and a theoretical pI of 6.91.
Recombinant 1(XI)Npp was recovered from inclusion bodies.
After unfolding and refolding, recombinant 1(XI)Npp was
purified by nickel-chelation chromatography (Fig. 1). Puri-
fied bacterial recombinant 1(XI)Npp co-migrated with hu-
man embryonic kidney 293 recombinant 1(XI)Npp by SDS-
polyacrylamide gel electrophoresis (data not shown).
Unfolded and refolded 1(XI)Npp was previously character-
ized by spectropolarimetry, electron microscopy, and LCQ-
MS/MS (17).
Detection of Interaction Using Yeast Two-hybrid System—
Expression vectors encoding fusion proteins between the DNA
binding domain of GAL4 and 1(XI)Npp and between the tran-
scriptional activation domain of GAL4 and 1(XI)Npp were
constructed. Cells cotransfected with both constructs were able
to grow in the absence of histidine (Fig. 2), indicating an inter-
action between the 1(XI)Npp domain portion of each of the
fusion proteins. Interaction was also demonstrated by detection
of -galactosidase activity (Fig. 2C). The level of -galactosid-
ase activity in double transformants was 10-fold higher than
background.
Size Exclusion Chromatography and Multi-angle Laser Light
Scatter—At physiological ionic strength (175 mM), the weight
average molar mass varied from the molecular mass of a mon-
omer (25,000 g/mol) at the trailing edge of the size exclusion
chromatography peak to 40,000 g/mol, an average molar mass
lying between that of a dimer (50,000 g/mol) and a monomer at
the leading edge of the peak (Fig. 3). Interaction was favored by
low ionic strength (75 mM) and disrupted by high ionic strength
(500 mM). Maximum molecular weight observed corresponded
to a dimer with no indication of higher multimerization. Mul-
timerization was inferred by an increase in molar mass of
purified recombinant 1(XI)Npp.
ELISA—Binding was shown to be saturable by ELISA (Fig.
4) in which recombinant 1(XI)Npp was bound to the plate and
a tagged recombinant isoform of 1(XI) amino-terminal domain
was allowed to interact with the 1(XI)Npp bound to the plate.
Antibody to the unique region of the alternate isoform was used
to detect interaction. This antibody did not recognize
1(XI)Npp. The dissociation constant was determined to be on
the order of 0.13 M.
Specificity of 1(XI)Npp Interaction: Co-precipitation of En-
dogenous and Recombinant 1(XI)Npp—Bovine chondrocytes
maintained in pellet culture were used as a source of cartilage
extracellular matrix proteins. Extracts were prepared from
10-day pellets using 1 M NaCl in Tris buffer in the absence of
denaturants. These extracts were incubated with recombinant
1(XI)Npp bound to agarose beads. Samples were analyzed by
SDS-polyacrylamide gel electrophoresis and subsequent immu-
noblot (Fig. 5). As a control, endogenous 2(XI)Npp was ana-
lyzed for its ability to bind to recombinant 1(XI)Npp under the
same conditions. Using an 2(XI)-specific antibody, 2(XI)Npp
was found primarily in the free fraction, whereas bovine
1(XI)Npp bound to the recombinant 1(XI)Npp-agarose beads
(Fig. 5).
Specificity of Antibody for the Endogenous 1(XI)Npp—The
ability of the 1(XI)Npp antibody to discriminate between en-
dogenous and recombinant 1(XI)Npp was demonstrated by
immunoblot and nickel affinity blot (Fig. 6). Samples of increas-
ing amounts of recombinant 1(XI)Npp were loaded onto an
SDS gel and subsequently transferred to polyvinylidene di-
fluoride membrane. Nickel-NTA-alkaline phosphatase conju-
gate was used to detect recombinant protein from a sample
that was three orders of magnitude more dilute than the
concentration needed for detection by the polyclonal antibody
to 1(XI)Npp. Location of the epitope site within the amino
propeptide and differences in amino acid sequence among the
peptide antigen, endogenous bovine sequence, and the se-
quence within the recombinant protein are demonstrated in
Fig. 6C.
FIG. 1. Expression of recombinant rat 1(XI)Npp. A, schematic
representation of the amino-terminal domain of a type XI collagen
molecule. The Npp of the 1(XI) chain is shown as a terminal globular
domain attached to the minor helix (mh) via an extended variable
region (vr). The 2(XI)Npp is absent from this schematic to represent
the rapid proteolytic processing of this chain. Between the minor helix
and the major triple helix (TH) lies the amino telopeptide (tp). Black bar
represents location of antibody recognition site. B, extracts of E. coli
cells grown in the presence of IPTG were resolved by SDS-PAGE on a
12% polyacrylamide gel stained with Coomassie Blue. Lane 1, molecu-
lar weight markers; lane 2, mid-log culture grown in the absence of
IPTG; lane 3, mid-log culture grown in the presence of IPTG; lane 4,
insoluble protein after extraction of E. coli cell pellet; lane 5, soluble
protein after protein extraction; lane 6, flow-through from nickel-affin-
ity column; lane 7, column wash; lanes 8 and 9, elution of purified,
refolded recombinant protein; lane 10, recombinant protein markers.
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Interaction in Chondrocyte Pellet Culture System Resulted in
a Stable Association—Recombinant 1(XI)Npp was converted
from a protein that migrated as an30-kDa protein to one that
had an apparent molecular mass of 60 kDa under denaturing
and reducing conditions when incubated for 24 h with bovine
chondrocytes maintained in pellet culture. Both the 30- and
60-kDa bands were detectable via the His6 tag by Nickel affin-
ity blot (Fig. 7). Using the 1(XI)Npp antibody that can dis-
criminate between recombinant and endogenous bovine
1(XI)Npp, the 60-kDa band was also recognized by this anti-
body, suggesting the formation of a dimer of 1(XI)Npp mono-
mers, one contributed by the endogenous bovine 1(XI) and the
other by the added recombinant 1(XI)Npp. In addition, a band
with an apparent molecular mass of 35 kDa was identified as
immunologically related to endogenous 1(XI)Npp. The nature
of this band is currently unknown. Stability of the 60-kDa band
FIG. 2. Detection of 1(XI)Npp:
1(XI)Npp interaction by yeast two-
hybrid system. A, yeast transformants
plated on selective media (minus trypto-
phan and minus leucine) as indicated in
schematic. B, single and double transfor-
mants plated in the absence of trypto-
phan-, leucine-, and histidine-selective
medium. C, -galactosidase activity de-
tected by colony lift and liquid culture
assay.
FIG. 3. Npp:Npp interaction de-
tected by size exclusion chromatog-
raphy and light scattering. Weight av-
erage molar mass plotted as a function of
elution volume from TSK 3000SW col-
umn. Buffer conditions varied from low
ionic strength, 75 mM (diamonds), physi-
ological ionic strength, 175 mM (squares),
and high ionic strength, 500 mM (). Av-
erage molecular weight values are shown
for the trailing and leading edges of chro-
matographic peaks.
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was investigated by subjecting samples to prolonged incubation
in the presence of 250 mM imidazole, EDTA, or -mercaptoeth-
anol at 90 °C with no change observed in migration on SDS
gels. The generation of the 60-kDa band during 24 h in bovine
pellet culture was not inhibited by inclusion of -aminopropi-
onitrile fumarate to inhibit lysine-derived covalent cross-link-
ing or by inclusion of putrescine to inhibit transglutaminase in
the culture (data not shown). To rule out a possible interaction
mediated by the His6 tag present on the recombinant protein,
recombinant 1(XI)Npp was generated without a His6 tag, by
removing the carboxyl domain from the recombinant 1(XI)
amino-terminal domain isoform by enzymatic proteolysis with
BMP-1 (Fig. 7, lanes 6 and 7). The resulting recombinant
1(XI)Npp was included in chondrocyte cell culture with simi-
lar results (Fig. 7).
DISCUSSION
The 1 chain of type XI collagen exists as a set of isoforms
that arise by alternative splicing of the primary RNA tran-
script. The portion encoding the variable region gives rise to
biochemically unique domains. However, common to all iso-
forms is the amino propeptide, the distal globular 233 amino
FIG. 4. ELISA assay. Binding was
shown to be saturable by ELISA assay in
which recombinant 1(XI)Npp was bound
to the plate and tagged recombinant
1(XI) amino-terminal domain was al-
lowed to interact with the bound
1(XI)Npp. Antibody to the unique tag
region was used to detect interaction. Ab-
sorbance at 405 nm was plotted as a func-
tion of tagged 1(XI) concentration (f).
This antibody did not recognize
1(XI)Npp. Inset depicts the results of
Scatchard analysis of binding. Bovine se-
rum albumin was used as a control for
nonspecific interaction (✖). Error bars in-
dicate  S.E.
FIG. 5. Specificity of 1(XI)Npp interaction by co-precipitation
of endogenous 1(XI)Npp with recombinant 1(XI)Npp-nickel-
agarose. Proteins were extracted from chondrocyte pellet cultures in 1
M NaCl-containing buffer. Buffer conditions were changed by dialysis to
reduce the salt concentration to 150 mM NaCl, and extract was incu-
bated with 1(XI)Npp-bound nickel-agarose beads. Proteins were re-
solved by SDS-PAGE 12% polyacrylamide gel and analyzed by immu-
noblot using an antibody to 1(XI)Npp and an antibody to 2(XI)Npp.
Lanes 1 and 3, material not bound to 1(XI)Npp-bound nickel-agarose
beads. Lanes 2 and 4, material bound to 1(XI)Npp-bound nickel-aga-
rose beads. Lanes 1 and 2, immunoblot with 2(XI)Npp antibody. Lanes
3 and 4, immunoblot with 1(XI)Npp antibody. Lane 5, molecular
weight markers. Arrows on left-hand side indicate position of the
1(XI)Npp and the 2(XI)Npp.
FIG. 6. Characterization of specificity of antibody and re-
combinant 1(XI)Npp. Specific changes made to the recombinant
1(XI)Npp allowed the antibody to distinguish endogenous bovine
1(XI)Npp from recombinant rat 1(XI)Npp. A, recombinant 1(XI)Npp
in 10 increasing incremental concentration curve. Lane 1, 0.01-
g protein; lane 2, 0.1-g protein; lane 3, 1-g protein; lane 4, 10-g
protein; lane 5, molecular weight markers, 43 and 28 kDa; lane 6, 0.1-
g protein; lane 7, 1.0-g protein; lane 8, 10-g protein. B, nickel
affinity and immunoblot of recombinant protein. Lanes 1–8, same sam-
ples as in A. Lanes 1–4, nickel affinity blot; lanes 6–8, immunoblot with
1(XI)Npp antibody. C, sequence of antigenic peptide compared with
the analogous site in bovine and rat 1(XI)Npp and with the sequence
of the recombinant protein. Although the antibody recognized endoge-
nous rat 1(XI) collagen chains, it did not recognize the recombinant
protein. The proteolytic processing site is indicated by the arrow.
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acids, which is ultimately proteolytically removed during the
process of extracellular matrix assembly and fibril formation.
Although the amino propeptide domain is thought to play a role
in the regulation of fibril diameter, the molecular mechanism of
this event is not fully understood.
A homotypic interaction was detected among the 1(XI)Npp
domains. The possibility of such an interaction was supported
by the use of multi-angle laser light scattering by which puri-
fied recombinant Npp was found to exist in equilibrium be-
tween monomer and dimer. Yeast-two hybrid system also sup-
ported the possibility that an interaction between two
1(XI)Npp domains could exist.
Freshly isolated chondrocytes were maintained as pellet cul-
tures under conditions that allow the maintenance of the chon-
drocyte phenotype and reestablishment of a characteristic car-
tilage extracellular matrix. The newly synthesized matrix
constituents were used as a source of cartilage matrix candi-
dates for this study. An interaction between recombinant rat
1(XI)Npp and endogenous bovine 1(XI)Npp was detected by
co-precipitation. The interaction resulted in a stable and ap-
parently covalent cross-link. The interaction was neither a
result of lysine-derived cross-linking nor transglutaminase-me-
diated cross-links as -aminopropionitrile fumarate or putres-
cine did not inhibit the cross-link. The interaction was also not
mediated by the His6 tag present on the recombinant protein.
Noncollagenous domains of other collagens have been reported
to form stable interactions including type X collagen (21–23),
type IV collagen (24, 25), type IX collagen (26), and type VIII
collagen (27). However, no such interaction has been described
for any of the other fibrillar collagens and no such interactions
have been described between propeptide domains. In the case
of types IV and X, the interactions were hydrophobic in nature
rather than due to covalent bond formation. In the case of the
type XI 1 Npp dimer, the stable interaction takes place only in
the presence of living cells because incubation of purified Npp
does not result in the appearance of higher molecular weight
bands on subsequent SDS gels, neither does the incubation of
mixtures of recombinant isoforms of 1(XI) amino-terminal
domain that contains any of the possible variable domains
adjacent to the Npp domain (data not shown). This interaction
may because of hydrophobic interaction or may be the result of
covalent bond formation between the two Npp subunits. Data
from the light scattering experiments do not support a hydro-
phobic interaction, because a decrease in average molecular
weight was observed with increasing ionic strength of the
buffer. If the stable interaction is the result of the formation of
a covalent bond, it is unknown what enzyme is responsible at
this time.
Type XI collagen serves primarily a regulatory function in
collagen fibrillogenesis. The interaction between 1(XI)Npp
domains demonstrated in this study may be coupled to enzy-
matic events including covalent cross-linking of amino propep-
tide domains and proteolytic cleavage to remove these domains
from collagen fibrils. Such an interaction could contribute to
our understanding of 1) initial nucleation of collagen fibrils, 2)
lateral fusion of preexisting thin fibrils, and 3) increase in
diameter because of accretion of individual collagen molecules
to the surface of a growing collagen fibril.
The role of type XI collagen in limitation of lateral growth of
collagen fibrils is well established, although the molecular
mechanism is not fully understood. The 1(XI)Npp has been
localized to the surface of thin collagen fibrils, it is relatively
long-lived at the surface, and it is clear from the molecular
dimensions that the 1(XI)Npp, the variable region, and the
minor helix would not be accommodated within the gap region
and would therefore sterically hinder further accretion of type
II collagen molecules to the surface of a growing fibril. An
interaction between Npp domains that favor proteolytic re-
moval of globular domains from the surface may facilitate
lateral growth of collagen fibrils.
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